Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
CORO1C pseudogene 1 (CORO1CP1) is classified as a pseudogene, which is a region of the genome that contains a non-functional, defective copy of the parental protein-coding gene CORO1C[5][6]. Pseudogenes typically arise from gene duplication or retrotransposition events and, due to mutations such as premature stop codons or frameshifts, do not produce a functional protein product[4][6][5]. There is no evidence that CORO1CP1 acts as a receptor, enzyme, or other molecular target, nor that it has current relevance for therapeutics, molecular pathway modulation, or use as a biomarker. All disease and functional associations in the literature are attributed to the active protein-coding gene CORO1C, not its pseudogene[1][2][3]. Thus, CORO1C pseudogene 1 is **not** a drug target, has no characterized biological function or disease role, and does not mediate therapeutic mechanisms. If information about the actual protein-coding **CORO1C** gene is needed, refer directly to "coronin 1C" or "CORO1C" rather than this non-coding pseudogene form[5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on CORO1C pseudogene 1 (CORO1CP1).